Analysis of Ki-67 expression in oral squamous cell carcinoma: Why Ki-67 is not a prognostic indicator

Oral Oncology

Volumn 46, Issue 7, 2010, Pages 525-530

  Gonzalez Moles, M A ^a   Ruiz Avila, I ^b   Gil Montoya, J A ^a   Esteban, F ^c   Bravo, M ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b Pathology Department   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Ki 67; Oral cancer; Prognostic factor

Indexed keywords

KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; SPAIN; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77953535364     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2010.03.020     Document Type: Article

References (44)

1. van Diest P.J., Brugal G., and Baak J.P.A. Proliferation markers in tumours: interpretation and clinical value. J Clin Pathol 51 (1998) 716-724
2. Tubiana M., and Courdi A. Cell proliferation kinetics in human solid tumors: relation to probability of metastatic dissemination and long term survival. Radiother Oncol 15 (1989) 1-18
3. Pich A., Chiusa L., and Navone R. Prognostic relevance of cell proliferation in head and neck tumors. Ann Oncol 15 9 (2004) 1319-1329
4. Gerdes J., Schwab U., Lemke H., and Stein H. Production of a monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31 (1983) 13-20
5. Cattoretti G., Becker M.H., Key G., Duchrow M., Schlüter C., Galle J., et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB-1 and MIB-3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168 (1992) 357-363
6. Sittel C., Ruiz S., Volling P., Kvasnicka H.M., Jungehülsing M., and Eckel H.E. Prognostic significance of Ki-67 (MIB 1), PCNA and p53 in cancer of the oropharynx and oral cavity. Oral Oncol 35 (1999) 583-589
7. Girod S.C., Pfeiffer P., Ries J., and Pape H.D. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma. Br J Oral Maxillofac Surg 36 (1998) 252-260
8. Matsumoto M., Komiyama K., Okaue M., Shimoyama Y., Iwakami K., Namaki S., et al. Predicting tumor metastasis in patients with oral cancer by means of the proliferation marker KI67. J Oral Sci 41 (1999) 53-56
9. Xie X., De Angelis P., Clausen O.P., and Boysen M. Prognostic significance of proliferative and apoptotic markers in oral tongue squamous cell carcinomas. Oral Oncol 35 (1999) 502-509
10. Lee J., Jin B., Kim M., Yoon H., Hong S., and Hong S. Prognostic significance of CXCR-4 expression in oral squamous cell carcinoma. OOOOE 107 (2009) 678-684
11. Roland N.J., Caslin A.W., Bowie G.L., and Jones A.S. Has the cellular proliferation marker Ki67 any clinical relevance in squamous cell carcinoma of the head and neck?. Clin Otolaryngol 19 (1994) 13-18
12. Valente G., Orecchia R., Gandolfo S., Arnaudo M., Ragona R., Kerim S., et al. Can Ki67 immunostaining predict response to radiotherapy in oral squamous cell carcinoma?. J Clin Pathol 47 (1994) 109-112
13. Gonzalez-Moles M.A., Caballero R., Rodriguez-Archilla A., Ruiz-Avila I., and Bravo I. Prognosis value of the expression of Ki-67 for squamous cell carcinoma of the oral cavity. Acta Stomatol Belg 93 (1996) 159-165
14. Piffkó J., Bánkfalvi A., Ofner D., Kusch F., Böcker W., Joos U., et al. In situ assessment of cell proliferation at the invasive front of oral squamous cell carcinomas. Virchows Arch 429 (1996) 229-234
15. Stoll C., Baretton G., Ahrens C., and Lohrs U. Prognostic significance of apoptosis and associated factors in oral squamous cell carcinoma. Virchows Arch 436 (2000) 102-108
16. Bettendorf O., and Herrmann G. Prognostic relevance of Ki-67 antigen expression in 329 cases of oral squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec 64 (2002) 200-205
17. Carinci F., Stabellini G., Calvitti M., Pelucchi S., Targa L., Farina A., et al. CD44 as prognostic factor in oral and oropharyngeal squamous cell carcinoma. J Craniofac Surg 13 (2002) 85-89
18. Okamoto M., Nishimine M., Kishi M., Kirita T., Sugimura M., Nakamura M., et al. Prediction of delayed neck metastasis in patients with stage I/II squamous cell carcinoma of the tongue. J Oral Pathol Med 31 (2002) 227-233
19. Shah N.G., Trivedi T., Tankshali R.A., Goswami J.V., Jetly D.H., Shukla S.N., et al. Prognosis significance of molecular marker in oral squamous cell carcinoma: a multivariate analysis. Head Neck 31 (2009) 1544-1556
20. Torres-Rendon A., Roy S., Craig G.T., and Speight P.M. Expression of Mcm2, geminin and Ki67 in normal oral mucosa, oral epithelial dysplasias and their corresponding squamous-cell carcinomas. Br J Cancer 100 (2009) 1128-1134
21. Johnson N., Franceschi S., Ferlay J., et al. Squamous cell carcinoma. In: Barnes L., Eveson J.W., Reichart P., and Sidransky D. (Eds). Pathology and genetics. Head and neck tumours (2005), IARC Press, Lyon 168-175
22. Tabor M.P., Brakenhoff R.H., Ruijter-Schippers H.J., Van Der Wal J.E., Snow G.B., Lemans C.R., et al. Multiple head and neck tumors frequently originate from a single preneoplastic lesion. Am J Pathol 161 3 (2002) 1051-1060
23. Hong W.K., Lippman S.M., Itri L.M., Karp D.D., Lee J.S., Byers R.M., et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 323 (1990) 795-801
24. Hashibe M., Ritz B., Le A.D., Li G., Sankaranarayanan R., and Zhang Z.F. Radiotherapy for oral cancer as a risk factor for second primary cancers. Cancer Lett 220 2 (2005) 185-195
25. van Houten V.M., Tabor M.P., van den Brekel M.W., Kummer J.A., Denkers F., Dijkstra J., et al. Mutated P53 as molecular marker for the diagnosis of head and neck cancer. J Pathol 198 (2002) 476-486
26. Woolgar J.A. Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma. Oral Oncol 42 (2006) 229-239
27. Shah B.V., BarnWell B.G., and Bieler G.S. SUDAAN software for the statistical analysis of correlated data. User's manual. Release 7.0 (1996), Research Triangle Institute, Research Triangle Park, NC
28. Doménech J.M., and Sarriá A. Análisis de supervivencia (1993), Editorial Gráficas Signo SA, Barcelona
29. Doménech J.M., and Sarriá A. Modelo de regresión de Cox (1993), Editorial Gráficas Signo SA, Barcelona
30. Derenzini M., Sirri V., Trere D., and Ochs R.L. The quantity of nucleolar proteins nucleolin and protein B23 is related to cell doubling time in human cancer cells. Lab Invest 73 (1995) 497-502
31. Dong H., Bertler C., Schneider E., and Ritter M.A. Assessment of cell proliferation by AgNOR scores and Ki-67 labeling indices and a comparison with potential doubling times. Cytometry 28 (1997) 280-288
32. Janes S.M., Lowell S., and Hutter C. Epidermal stem cells. J Pathol 197 4 (2002) 479-491
33. Mackenzie I.C. Stem cell properties and epithelial malignancies. Eur J Cancer 42 9 (2006) 1204-1212
34. Barrandon Y., and Green H. Three clonal types of keratinocyte with different capacities for multiplication. Proc Natl Acad Sci USA 84 (1987) 2302-2306
35. Jones P.H., and Watt F.M. Separation of human epidermal stem-cells from transit amplifying cells on the basis of differences in integrin function and expression. Cell 73 (1993) 713-724
36. Reya T., Morrison S.J., Clarke M.F., and Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 414 6859 (2001) 105-111
37. Locke M., Heywood M., Fawell S., and Mackenzie I.C. Retention of intrinsic stem cell hierarchies in carcinoma-derived cell lines. Cancer Res 65 19 (2005) 8944-8950
38. Denekamp J. Tumour stem cells: facts, interpretation and consequences. Radiother Oncol 30 1 (1994) 6-10
39. González-Moles MA, Bravo M, Ruiz-Ávila I, Acebal F, Gil-Montoya JA, Brener S, et al. Ki-67 expression in non-tumour epithelium adjacent to oral cancer as risk marker for multiple oral tumours. Oral Dis, in press. doi:10.1111/j.1601-0825.2009.01611.
40. Tabor M.P., Brakenhoff R.H., Ruijter-Schippers H.J., Van Der Wal J.E., Snow G.B., Leemans C.R., et al. Comparative molecular and histological grading of epithelial dysplasia of the oral cavity and the oropharynx. J Pathol 199 (2003) 354-360
41. Gonzalez-Moles M.A., Esteban F., Rodriguez-Archilla A., Ruiz-Avila I., and Gonzalez-Moles S. Importance of tumour thickness measurement in prognosis of tongue cancer. Oral Oncol 38 4 (2002) 394-397
42. Gonzalez-Moles M.A., Bravo M., Ruiz-Avila I., Esteban F., Rodriguez-Archilla A., Gonzalez-Moles S., et al. Adhesion molecule CD44 as a prognostic factor in tongue cancer. Anticancer Res 23 6D (2003) 5197-5202
43. González-Moles M.A., Bravo M., Ruiz-Avila I., Esteban F., Bascones-Martínez A., and González-Moles S. Adhesion molecule CD44 expression in non-tumour epithelium adjacent to tongue cancer. Oral Oncol 40 3 (2004) 281-286
44. de Vicente J.C., Fresno M.F., Villalain L., Vega J.A., and Hernández Vallejo G. Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma. Oral Oncol 41 3 (2005) 283-293